News

Twenty-nine doctoral, 36 master’s and 154 baccalaureate candidates were eligible to receive degrees in biomedical science fields during the May commencement ceremony.

New stem cell research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, has identified novel therapeutic targets for the treatment of multiple sclerosis (MS) and other inflammatory diseases.

Chelsey Reed, a student in the MD-PhD Program, has been awarded a prestigious fellowship from the National Institutes of Health (NIH).

A preclinical study conducted by researchers in the Department of Pharmacology and Toxicology has shown for the first time that a class of proteins are important in the neurobiology of relapse or drug-seeking behaviors.

David Dietz, PhD, associate professor, has been appointed chair of the Department of Pharmacology and Toxicology.

Research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, has identified a new drug target for remyelination in multiple sclerosis (MS).

Newly published research led by Robert Zivadinov, MD, PhD, professor of neurology, finds novel indicators for predicting worsening conditions in multiple sclerosis (MS) patients.

Researchers and their mentors in the Department of Pharmacology and Toxicology were honored for their in-depth studies presented at the 2018 Experimental Biology meeting and related forums.

Thirteen students from the Class of 2017-18 in the PhD Program in Biomedical Sciences (PPBS) took part in a white coat ceremony to recognize the completion of their first year in the program and celebrate their moving on to a research laboratory match.